{"id":"NCT00408317","sponsor":"Forest Laboratories","briefTitle":"Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)","officialTitle":"A Multicenter, Randomized, Double-Blind, Crossover Study to Compare the Safety and Efficacy of Ultrase® MT20 to Placebo for the Correction of Steatorrhea in Patients With Cystic Fibrosis (CF)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2007-04","completion":"2007-04","firstPosted":"2006-12-06","resultsPosted":"2014-03-12","lastUpdate":"2017-03-16"},"enrollment":36,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis","Exocrine Pancreatic Insufficiency"],"interventions":[{"type":"DRUG","name":"Ultrase® MT20","otherNames":["Pancreatic enzyme product"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ultrase® MT20","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and efficacy of Ultrase® MT20 compared to placebo for the correction of fat and protein malabsorption in participants with cystic fibrosis (CF) and exocrine pancreatic insufficiency (EPI). This study is sponsored by Aptalis Pharma (formerly Axcan).","primaryOutcome":{"measure":"Percent Coefficient of Fat Absorption (CFA)","timeFrame":"Day 3 to Day 7 in first intervention period and second intervention period","effectByArm":[{"arm":"Ultrase® MT20","deltaMin":88.55,"sd":4.94},{"arm":"Placebo","deltaMin":55.61,"sd":25.1}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":18},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Abdominal pain","Fecal fat increased","Abdominal pain upper","Laboratory test abnormal","Flatulence"]}}